Drugs / VIPADENANT
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 13 trials | ||||||
| Phase 1 | NCT01035515 | Dec 2009 → Apr 2010 | — | Biogen | Completed | No outcome recorded |
| Phase 1 | NCT01017666 | Nov 2009 → Jun 2010 | — | Biogen | Completed | No outcome recorded |
| Phase 1 | NCT00531193 | Sep 2007 → Apr 2008 | — | Biogen | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT00438607 | Apr 2007 → Apr 2009 | Parkinson disease | Biogen | Completed | No outcome recorded |
| Phase 2 | NCT00451815 | — | Parkinson disease | Biogen | Withdrawn | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00442780 Comparator | Aug 2007 → Dec 2008 | Parkinson disease | Biogen | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 2
| Date | Issuer | Release |
|---|---|---|
| 2010-04-05 | Biogen | Results Biogen Idec Strengthens Position as a Leader in Neurology with 38 Data Presentations at 62nd Annual Meeting of the American Academy of Neurology biogen.com ↗ |
| 2009-03-25 | Biogen | Results Biogen Idec Highlights Progress and Breadth of Pipeline Programs at R&D Day biogen.com ↗
Interim results from this study were favorable and support continued development of BIIB014 in this setting. |
All press releases naming this drug 2 releases
Evidence & citations 12 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VIPADENANT | ChEMBL registry synonym — accepted as the source's own label CHEMBL447664 ↗ |
| Known as | BIIB014 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00451815 ↗ |
| Known as | CEB-4520 | ChEMBL registry synonym — accepted as the source's own label CHEMBL447664 ↗ |
| Known as | V-2006 | ChEMBL registry synonym — accepted as the source's own label CHEMBL447664 ↗ |
| Known as | VER-11135 | ChEMBL registry synonym — accepted as the source's own label CHEMBL447664 ↗ |
| Known as | VER-A-00-11 | ChEMBL registry synonym — accepted as the source's own label CHEMBL447664 ↗ |
| Known as | VER-A-00049 | ChEMBL registry synonym — accepted as the source's own label CHEMBL447664 ↗ |
| Known as | VER-ADO-49 | ChEMBL registry synonym — accepted as the source's own label CHEMBL447664 ↗ |
| Action | Inhibit | “Adenosine A2a receptor antagonist” CHEMBL447664 ↗ |
| Modality | Small molecule | — CHEMBL447664 ↗ |
| Route | Oral | “oral administration of BIIB014” NCT00438607 ↗ |
| Target | ADORA2A | “Adenosine A2a receptor antagonist” CHEMBL447664 ↗ |